← Previous Post: | Next Post:

 

“The study was led by professor Hiroaki Matsubara, and included among its researchers an un-named Novartis employee, who was identified as an adjunct lecturer at Osaka City University.”

No better way to optimize your Novartis-funded results on a Novartis drug than to place a Novartis employee on your faculty and put that person in charge of statistical results. This research protocol all but guarantees that your results will be in line with corporate efforts in this case to establish the drug as effective for pretty much any human ill you can think of. And that is just what happened!

The Novartis plant held the same position in four other Japanese university labs. Truly an impressive effort on the drug-maker’s part.

Margaret Soltan, July 12, 2013 2:10PM
Posted in: conflict of interest, march of science

Trackback URL for this post:
https://www.margaretsoltan.com/wp-trackback.php?p=40493

Comment on this Entry

Latest UD posts at IHE

Archives

Categories